AC5 Surgical Hemostat™ as an effective hemostatic agent in an anticoagulated rat liver punch biopsy model

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 8, 2015, Pages 2025-2031

  Csukas, Domokos ^a   Urbanics, Rudolf ^a,b   Moritz, Annie ^c   Ellis Behnke, Rutledge ^d,e  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SeroScience Ltd   (Hungary)

^c UNIVERSITY OF MANNHEIM   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

AC5 ; Anticoagulant; Hemostasis; Heparin; Rat hepatic bleeding model

Indexed keywords

BIOPSY; PEPTIDES; POLYSACCHARIDES; RATS; SELF ASSEMBLY; SURGERY;

ANTICOAGULANT; ANTICOAGULANT THERAPY; ANTICOAGULATION THERAPY; HEMOSTASIS; HEMOSTATIC AGENTS; HEPARIN; SELF-ASSEMBLING PEPTIDES; SURGICAL PROCEDURES;

ANIMALS;

HEMOSTATIC AGENT; HEPARIN; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CONTROLLED STUDY; HEMOSTASIS; LIVER BIOPSY; MALE; MOUSE; NONHUMAN; PUNCH BIOPSY; ANIMAL; BIOPSY; BLOOD CLOTTING; BLOOD LOSS, SURGICAL; DISEASE MODEL; DRUG EFFECTS; HEMORRHAGE; INJURIES; LIVER; RAT; WISTAR RAT;

ANIMALS; ANTICOAGULANTS; BIOPSY; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; DISEASE MODELS, ANIMAL; HEMORRHAGE; HEMOSTASIS; HEMOSTATICS; HEPARIN; LIVER; MALE; PEPTIDES; RATS; RATS, WISTAR;

EID: 84951168319     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.01.001     Document Type: Article

References (20)

1. McCarthy J.R. Methods for assuring surgical hemostasis. Assisting in surgery: patient-centered care 2009, 137-194. CCI, Denver, CO. J.C. Rothrock, P.C. Seifert (Eds.).
2. Spyropoulos A.C., Douketis J.D. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012, 120(15):2954-2962.
3. Schreiber M.A., Neveleff D.J. Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings. AORN J 2011, 94(5):S4-S20.
4. Douketis J.D., Spyropoulos A.C., Spencer F.A., Mayr M., Jaffer A.K., Eckman M.H., et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis. Chest 2012, 141(2 Suppl.):e326S-e350S. 9th ed.
5. Mitchell M.D., Anderson B.J., Williams K., Umscheid C.A. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs 2009, 65(10):2007-2021.
6. Le Roux P., Pollack C.V., Milan M., Schaefer A. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. J Neurosurg 2014, 121:1-20.
7. Burks S., Spotnitz W. Safety and usability of hemostats, sealants, and adhesives. AORN J 2014, 100:160-176.
8. Hoogerwerf B.J. Provide hemostasis. Competency for safe patient care during operative and invasive procedures 2009, 499-532. CCI, Denver, CO. M.L. Phippen, B.C. Ulmer, M.P. Wells (Eds.).
9. Ellis-Behnke R.G., Liang Y.X., Tay D.K.C., Kau P.W.F., Schneider G.E., Zhang S., et al. Nano hemostat solution: immediate hemostasis at the nanoscale. Nanomedicine 2006, 2:207-215.
10. Spotnitz W.D., Burks S. Hemostats sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox [state-of-the-art review]. Clin Appl Thromb Hemost 2010, 16(5):497-514.
11. Achneck H.E., Sileshi B., Jamiolkowski R.M., Albala D.M., Shapiro M.L., Lawson J.H. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 2010, 251(2):217-228.
12. Ochsner M.G., Maniscalco-Theberge M.E., Champion H.R. Fibrin glue as a hemostatic agent in hepatic and splenic trauma. J Trauma 1990, 30:884.
13. Surgicel® hemostat. Ethicon360 [Accessed September 5, 2014]. http://www.ethicon360.com/products/surgicel-family-absorbable-hemostats.
14. Progel® pleural air leak sealant. Davol [Accessed September 6, 2014]. http://www.davol.com/products/biosurgery/progel/.
15. Alam H.B., Burris D., DaCorta J.A., Rhee P. Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med 2005, 170:63-69.
16. Schonauer C., Tessitore E., Barbagallo G., Albanese V., Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur J Spine 2004, 13(Suppl. 1):S89-S96.
17. Hoffman M. The cellular basis of traumatic bleeding. Mil Med 2004, 169:5-7.
18. Masuhara H., Fujii T., Watanabe Y., Koyama N., Tokuhiro K. Novel infectious agent-free hemostatic material (TDM-621) in cardiovascular surgery. Ann Thorac Cardiovasc Surg 2012, 18:444-451.
19. Guo J., Su H., Zeng Y., Liang Y.X., Wong W.M., Ellis-Behnke R.G., So K.F., Wu W. Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. Nanomedicine 2007, 3:311-321.
20. Ellis-Behnke R.G., Liang Y.X., You S.W., Tay D.K.C., Zhang S., So K.F., Schneider G.E. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A 2006, 103:5054-5059.